1. bookVolume 3 (2020): Edition 1 (June 2020)
Détails du magazine
Première parution
30 Sep 2019
2 fois par an
Accès libre

In Vitro Effects of Various Probiotic Products on Growth and Biofilm Formation of Clinical UPEC Strains

Publié en ligne: 29 Jun 2020
Volume & Edition: Volume 3 (2020) - Edition 1 (June 2020)
Pages: 5 - 14
Reçu: 02 Jan 2020
Accepté: 05 Feb 2020
Détails du magazine
Première parution
30 Sep 2019
2 fois par an

1. Aminnezhad S, Kasra-Kermanshahi R (2014) Antibiofilm activity of cell-free supernatant from Lactobacillus casei in Pseudomonas aeruginosa. Feyz 18:30–7.Search in Google Scholar

2. Andersen TE, Khandige S, Madelung M, Brewer J, Kolmos HJ, Møller-Jensen J (2012) Escherichia coli uropathogenesis in vitro: invasion, cellular escape, and secondary infection analyzed in a human bladder cell infection model. Infect and Immun 80(5): 1858–67.10.1128/IAI.06075-11334743322354025Search in Google Scholar

3. Axe DD, Bailey JE (1995) Transport of lactate and acetate through the cytoplasmic membrane of Escherichia coli. Biotechnol Bioeng 47:8–19.10.1002/bit.26047010318623362Search in Google Scholar

4. Balaban N, Cirioni O, Giacometti A, Ghiselli R, Braunstein JB, Silvestri C, Mocchegiani F, Saba V, Scalise G (2007) Treatment of Staphylococcus aureus biofilm infection by the quorum-sensing inhibitor RIP. Antimicrob Agents Chemother 51:2226–9.10.1128/AAC.01097-06189138317371825Search in Google Scholar

5. Barken KB, Pamp SJ, Yang L, Gjermansen M, Bertrand JJ, Klausen M, Givskov M, Whitchurch CB, Engel JN, Tolker-Nielsen T (2008) Roles of type IV pili, flagellum-mediated motility and extracellular DNA in the formation of mature multicellular structures in Pseudomonas aeruginosa biofilms. Environ Microbiol 10:2331–43.10.1111/j.1462-2920.2008.01658.x18485000Search in Google Scholar

6. Bassler BL, Losick R (2006) “Bacterially speaking,” Cell 125(2):237–246.10.1016/j.cell.2006.04.00116630813Search in Google Scholar

7. Beerepoot M, Ter Riet G, Nys S, van der Wal WM, De Borgie CA, de Reijke TM (2012) Lactobacilli versus antibiotics to prevent urinary tract infections. A randomized double-blind non-inferiority trial in postmenopausal women. Arch Intern Med 172(9):704–712.Search in Google Scholar

8. Behnsen J, Deriu E, Sassone-Corsi M, Raffatellu M (2013) Probiotics: properties, examples, and specific applications. Cold Spring Harb Perspect Med 3:1–15.10.1101/cshperspect.a010074357920623457295Search in Google Scholar

9. Bower JM, Eto DS, Mulvey MA (2005) Covert operations of uropathogenic Escherichia coli within the urinary tract Traffic 6:18–31.10.1111/j.1600-0854.2004.00251.x252325915569242Search in Google Scholar

10. Cadieux PA1, Burton J, Devillard E, Reid G (2009) Lactobacillus by-products inhibit the growth and virulence of uropathogenic Escherichia coli. J Physiol Pharmacol 60 (Suppl 6):13–18.Search in Google Scholar

11. Christensen GD, Simpson WA, Younger JJ, Baddour LM, Barrett FF, Melton DM, Beachey EH (1985) Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 22:996–1006.10.1128/jcm.22.6.996-1006.19852718663905855Search in Google Scholar

12. Delley M, Bruttin A, Richard M, Affolter M, Rezzonico E, Brück WM (2015) In vitro activity of commercial probiotic Lactobacillus strains against uropathogenic Escherichia coli. FEMS Microbiology Lett 362(13).10.1093/femsle/fnv09626078118Search in Google Scholar

13. Diez-Gonzalez F, Russell JB (1997) The ability of Escherichia coli O157:H7 to decrease its intracellular pH and resist the toxicity of acetic acid. Microbiol 143:1175–118010.1099/00221287-143-4-11759141680Search in Google Scholar

14. Freestone P (2013) Communication between bacteria and their hosts. Scientifica 2013:1–1510.1155/2013/361073387190624381789Search in Google Scholar

15. Geerlings SE, Beerepoot MA, Prins JM (2014) Prevention of recurrent urinary tract infections in women: antimicrobial and nonantimicrobial strategies. Infect Dis Clin, 28(1):135–147.10.1016/j.idc.2013.10.00124484580Search in Google Scholar

16. Guandalini S (2011) Probiotics for prevention and treatment of diarrhea. J Clin Gastroenterol 45:149–153.10.1097/MCG.0b013e3182257e9821992955Search in Google Scholar

17. Guarino A, Vecchio AL, Canani RB (2009) Probiotics as prevention and treatment for diarrhea. Curr Opin Gastroenterol 25(1):18–23.10.1097/MOG.0b013e32831b445519114770Search in Google Scholar

18. Hacker J, Blum-Oehler G, Janke B, Nagy G, Goebel W (1999) Pathogenicity Islands of Extraintestinal Escherichia coli. In Kaper JB, Hacker J (eds) Pathogenicity Islands and Other Mobile Virulence Elements. Washington DC: ASM Press 59–76.10.1128/9781555818173.ch4Search in Google Scholar

19. Hagan EC, Mobley HLT (2007) Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection. Infect Immun 75:3941–9.10.1128/IAI.00337-07195197217517861Search in Google Scholar

20. Hunstad DA, Justice SS (2010) Intracellular lifestyles and immune evasion strategies of uropathogenic Escherichia coli. Annu Rev Microbiol 64:203–221.10.1146/annurev.micro.112408.13425820825346Search in Google Scholar

21. Karska-Wysocki B, Bazo M, Smoragiewicz W (2010) Antibacterial activity of Lactobacillus acidophilus and Lactobacillus casei against methicillin-resistant Staphylococcus aureus (MRSA). Microbiol Res 165(8):674–686.10.1016/j.micres.2009.11.00820116228Search in Google Scholar

22. Kim Y, Kim SH (2009) Released exopolysaccharide (r-EPS) produced from probiotic bacteria reduce biofilm formation of enterohemorrhagic Escherichia coli O157: H7. Biochem Biophys Res Commun 379:324–9.10.1016/j.bbrc.2008.12.05319103165Search in Google Scholar

23. Kulkarni R, Dhakal BK, Slechta ES, Kurtz Z, Mulvey MA, Thanassi DG (2009) Roles of putative type II secretion and type IV pilus systems in the virulence of uropathogenic Escherichia coli. PLoS One 4(3).10.1371/journal.pone.0004752264943119270734Search in Google Scholar

24. Kulkarni R, Dhakal BK, Slechta ES, Kurtz Z, Mulvey MA, Thaassi DG (2009) Roles of putative type II secretion and type IV pilus systems in the virulence of uropathogenic Escherichia coli. PLoS ONE 4:1–9.10.1371/journal.pone.0004752Search in Google Scholar

25. Lash BW, Mysliwiec TH, Gourama H, Mysliwiec TH (2005) Detection and partial characterization of a broad-range bacteriocin produced by Lactobacillus plantarum (ATCC 8014). Food Microbiol 22:199–204.10.1016/j.fm.2004.03.006Search in Google Scholar

26. Lee JH, Subhadra B, Son YJ, Kim DH, Park HS, Kim JM, Koo SH, Oh MH, Kim HJ, Choi CH (2016) Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea. Lett App Microbiol 62(1):84–90.10.1111/lam.12517Search in Google Scholar

27. Li D, Liu B, Chen M, Guo D, Guo X, Liu F, Feng L, Wang L (2010) A multiplex PCR method to detect 14 Escherichia coli serogroups associated with urinary tract infections. J Microbiol Methods 82:71–7.10.1016/j.mimet.2010.04.008Search in Google Scholar

28. Makino S, Ikegami S, Kano H, Sashihara T, Sugano H, Horiuchi H, Saito T, Oda M (2006) Immunomodulatory effects of polysaccharides produced by Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. J Dairy Sci 89:2873–81.10.3168/jds.S0022-0302(06)72560-7Search in Google Scholar

29. Mandal P, Kapil A, Goswami K, Das B, Dwivedi SN (2001) Uropathogenic Escherichia coli causing urinary tract infections. Indian J Med Res 114:207–11.Search in Google Scholar

30. Martín R, Suárez JE (2010) Biosynthesis and degradation of H2O2 by vaginal lactobacilli. Appl Environ Microbiol 76:400–405.10.1128/AEM.01631-09280522819948869Search in Google Scholar

31. Miyazaki J, Ba-Thein W, Kumao T, Obata Yasuoka M, Akaza H, Hayshi H (2002) Type 1, P and S fimbriae, and afimbrial adhesin I are not essential for uropathogenic Escherichia coli to adhere to and invade bladder epithelial cells. FEMS Immunol Med Microbiol 25:23–6.10.1111/j.1574-695X.2002.tb00567.x11985964Search in Google Scholar

32. Miyazaki Y, Yokota H, Takahashi H, Fukuda M, Kawakami H, Kamiya S, Hanawa T (2010) Effect of probiotic bacterial strains of Lactobacillus, Bifidobacterium, and Enterococcus on enteroaggregative Escherichia coli. J Infect Chemother 16(1):10–18.10.1007/s10156-009-0007-220054601Search in Google Scholar

33. Morais MBD, Jacob CMA (2006) The role of probiotics and prebiotics in pediatric practice. J de Pediat 82(5):189–97.Search in Google Scholar

34. Morelli L, Zonenenschain D, Del Piano M, Cognein P (2004) Utilization of the intestinal tract as a delivery system for urogenital probiotics. J Clin Gastroenterol 38:107–110.10.1097/01.mcg.0000128938.32835.9815220672Search in Google Scholar

35. Nader-Macías MEF, Silva de Ruiz C, Ocaña VS, Juárez Tomás MS (2008) Advances in the knowledge and clinical applications of lactic acid bacteria as probiotics in the urogenital tract. Curr Women’s Health Rev 4:240–257.10.2174/157340408786848214Search in Google Scholar

36. Nigam A, Kumar A, Madhusuda HV, Bhola N (2012) In-vitro Screening of antibacterial activity of lactic acid bacteria against common enteric pathogens Astha Nigam, Madhusudan HV, and Neelam Bhola Departmaent of Microbiology, CloneGen Biotechnology Ltd. J Biomed Sci 4(2):1–5.Search in Google Scholar

37. Ocana VS, Bru E, de Ruiz Holgado AA Nader-Macıas ME (1999) Surface characteristics of lactobacilli isolated from human vagina. J Gen Appl Microbiol 45:203–212.10.2323/jgam.45.203Search in Google Scholar

38. Ogawa M, Shimizu K, Nomoto K, Tanaka R, Hamabata T, Yamasaki S, Takeda T, Takeda Y (2001) Inhibition of in vitro growth of Shiga toxin-producing Escherichia coli O157:H7 by probiotic bacteria Lactobacillus strains due to production of latic acid. Int J Food Microbiol 68:135–140.10.1016/S0168-1605(01)00465-2Search in Google Scholar

39. Poppi LB, Rivaldi JD, CoutinhoTS, Astolfi-Ferreira CS, Ferreira AJP, Mancilha IM (2015) Effect of Lactobacillus sp. isolates supernatant on Escherichia coli O157: H7 enhances the role of organic acids production as a factor for pathogen control. Pesquisa Veterinária Brasileira 35(4):353–359.Search in Google Scholar

40. Ruiz J, Simon K, Horcajada JP, Velasco M, Barranco M, Roig G, Moreno-Martínez A, Martínez JA, Jiménez de Anta T, Mensa J, Vila J (2002) Differences in virulence factors among clinical isolates of Escherichia coli causing cystitis and pyelonephritis in women and prostatitis in men. J of Clin Microbiol 40:12:4445–49.10.1128/JCM.40.12.4445-4449.2002Search in Google Scholar

41. Saavedra J (2000) Probiotics and infectious diarrhea. Am J Gastroenterol 95(1) :16–18.10.1016/S0002-9270(99)00811-4Search in Google Scholar

42. Sabaté M, Moreno E, Pérez T, Andreu A, Prats G (2006) Pathogenicity island markers in commensal and uropathogenic Escherichia coli isolates. Clin Microbiol Infect 12:88010.1111/j.1469-0691.2006.01461.x16882293Search in Google Scholar

43. Sadri M, Arab Soleimani N, Forghanifard MM (2016) The study of Antimicrobial and Anti-adhesive effect of Probiotic Lactobacilli on Uropathogenic Escherichia coli (UPEC). Biol J Microorganism 5:159–70.Search in Google Scholar

44. Segarra-Newnham M (2007) Probiotics for Clostridium difficile–associated diarrhea: focus on Lactobacillus rhamnosus GG and Saccharomyces boulardii. Ann Pharmacother 41(7-8):1212-21.10.1345/aph.1K11017595306Search in Google Scholar

45. Servin AL (2004) Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev 28(4):405–440.10.1016/j.femsre.2004.01.00315374659Search in Google Scholar

46. Sivick K E, Mobley H L (2010) Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect Immun 78(2):568–585.Search in Google Scholar

47. Stoyancheva G, Marzotto M, Dellaglio F, Torriani S (2014) Bacteriocin production and gene sequencing analysis from vaginal Lactobacillus strains. Arch Microbiol 196:645–65310.1007/s00203-014-1003-124919535Search in Google Scholar

48. Terraf MCL, Tomás MSJ, Rault L, Le Loir Y, Even S, Nader-Macías MEF (2017) In vitro effect of vaginal lactobacilli on the growth and adhesion abilities of uropathogenic Escherichia coli. Arch Microbiol 199(5):767–774.10.1007/s00203-016-1336-z28280842Search in Google Scholar

49. Tomas J MS, Ocaña VS, Wiese B, Nader-Macías ME (2003) Growth and lactic acid production by vaginal Lactobacillus acidophilus CRL 1259, and inhibition of uropathogenic Escherichia coli. J Med Microbiol 52(12):1117-1124.10.1099/jmm.0.05155-014614071Search in Google Scholar

50. Tomás J MS, Saralegui Duhart CI, De Gregorio PR, Vera Pingitore E, Nader-Macías ME (2011) Urogenital pathogen inhibition and compatibility between vaginal Lactobacillus strains to be considered as probiotic candidates. Eur J Obstet Gynecol Reprod Biol 159:399–406.10.1016/j.ejogrb.2011.07.01021862199Search in Google Scholar

51. Turroni F, Ventura M, Butto LF. et al. (2014) Molecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective. Cell Mol Life Sci 71:183–203.10.1007/s00018-013-1318-023516017Search in Google Scholar

52. Uzun C, Oncül O, Gümüş D, Alan S, Dayioğlu N, Küçüker MA (2015) Virulence genes and antibiotic susceptibilities of uropathogenic E. coli strains. Clin Lab 61(8):941-950.Search in Google Scholar

53. Vacheva A, Georgieva R, Danova S, Mihova R, Marhova M, Kostadinova S, Stoitsova S (2012) Modulation of Escherichia coli biofilm growth by cell-free spent cultures from lactobacilli. Open Life Sci 7(2):219-229.10.2478/s11535-012-0004-9Search in Google Scholar

54. Wagner RD, Johnson SJ (2012) Probiotic lactobacillus and estrogen effects on vaginal epithelial gene expression responses to Candida albicans. J Biomed Sci 19(1):58.Search in Google Scholar

55. Wang J, Zhao X, Yang Y, Zhao A, Yang Z (2015) Characterization and bioactivities of an exopolysaccharide produced by Lactobacillus plantarum YW32. Int J Biol Macromol 74:119-26.10.1016/j.ijbiomac.2014.12.00625532782Search in Google Scholar

56. Waters CM, Bassler BL (2005) “Quorum sensing: cell-to-cell communication in bacteria”. Annu Rev Cell Dev Biol 21:319–346.10.1146/annurev.cellbio.21.012704.13100116212498Search in Google Scholar

57. Wu CC, Lin CT, Wu CY, Peng WS, Lee MJ, Tsai YC (2015) Inhibitory effect of Lactobacillus salivarius on Streptococcus mutans biofilm formation. Mol Oral Microbiol 30(1):16–26.Search in Google Scholar

58. Yamamoto S (2007) Molecular epidemiology of Escherichia coli. J Infect Chemother 13:68–73.10.1007/s10156-007-0506-Y17458672Search in Google Scholar

59. Zamani H, Rahbar S, Garakoui SR, Afsah Sahebi A, Jafari H (2017) Antibiofilm potential of Lactobacillus plantarum spp. cell free supernatant (CFS) against multidrug resistant bacterial pathogens. Pharma Biomed Res 3(2):39–44.Search in Google Scholar

60. ***FAO/WHO (2001). Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. Cordoba, Argentina: WHO.Search in Google Scholar

Articles recommandés par Trend MD

Planifiez votre conférence à distance avec Sciendo